Rooney CM - Search Results

1

Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.

Vigouroux S, Yvon E, Wagner HJ, Biagi E, Dotti G, Sili U, Lira C, Rooney CM, Brenner MK. Vigouroux S, et al. Among authors: rooney cm. J Virol. 2003 Oct;77(20):10872-80. doi: 10.1128/jvi.77.20.10872-10880.2003. J Virol. 2003. PMID: 14512537 Free PMC article.

2

Transfection and gene expression in normal and malignant primary B lymphocytes.

Buschle M, Brenner MK, Chen IS, Drexler HG, Gignac SM, Rooney CM. Buschle M, et al. Among authors: rooney cm. J Immunol Methods. 1990 Oct 4;133(1):77-85. doi: 10.1016/0022-1759(90)90321-l. J Immunol Methods. 1990. PMID: 1698880

3

Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation.

Rooney CM, Wimperis JZ, Brenner MK, Patterson J, Hoffbrand AV, Prentice HG. Rooney CM, et al. Br J Haematol. 1986 Mar;62(3):413-20. doi: 10.1111/j.1365-2141.1986.tb02952.x. Br J Haematol. 1986. PMID: 3513817

4

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

5

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2. Lancet. 1995. PMID: 7799740

6

Donor T cells to treat EBV-associated lymphoma.

Heslop HE, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. N Engl J Med. 1994 Sep 8;331(10):679-80. doi: 10.1056/NEJM199409083311017. N Engl J Med. 1994. PMID: 8052285 No abstract available.

7

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Nat Med. 1996 May;2(5):551-5. doi: 10.1038/nm0596-551. Nat Med. 1996. PMID: 8616714

8

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

Smith CA, Woodruff LS, Kitchingman GR, Rooney CM. Smith CA, et al. Among authors: rooney cm. J Virol. 1996 Oct;70(10):6733-40. doi: 10.1128/JVI.70.10.6733-6740.1996. J Virol. 1996. PMID: 8794310 Free PMC article.

9

Gene-marking and haemopoietic stem-cell transplantation.

Heslop HE, Rooney CM, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Blood Rev. 1995 Dec;9(4):220-5. doi: 10.1016/s0268-960x(95)90013-6. Blood Rev. 1995. PMID: 8839397 Review.

10

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.

Smith CA, Ng CY, Loftin SK, Li C, Heslop HE, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. Leuk Lymphoma. 1996 Oct;23(3-4):213-20. doi: 10.3109/10428199609054823. Leuk Lymphoma. 1996. PMID: 9031101 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters